Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danqing Zhao

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Oncology|November 20, 2025
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort StudyZiqian Wang, Chong Wei, Kai-Ni Shen, et al.
Annals of Hematology|July 31, 2023
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two casesYupeng Wang, Zi Wang, Chong Wei, et al.
Annals of Hematology|May 15, 2026
TP53 mutations and baseline lymphocytes indicate response to glofitamab in relapsed or refractory diffuse large B-cell lymphomaJing Ruan, Yan Zhang, Daobin Zhou, et al.
Frontiers in Endocrinology|March 13, 2026
Long-term risk of all-cause mortality and cardiovascular events in women with gestational diabetes mellitus: a systematic review and meta-analysisHong Zeng, Xiaoping Yin, Li Yin, et al.
Medicine|March 10, 2023
Efficacy of catheter ablation for atrial fibrillation in patients with significant functional mitral regurgitationDanqing Zhao, Futao Zhang, Xiaojie Liu, et al.
Clinical and Experimental Medicine|March 1, 2024
Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcomeHongyun Chen, Jinrong Zhao, Danqing Zhao, et al.
Frontiers in Oncology|January 10, 2022
Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case SeriesYan Zhang, Yanan Li, Zhe Zhuang, et al.
Proteomics. Clinical Applications|February 22, 2017
Identification of candidate biomarkers for the prediction of gestational diabetes mellitus in the early stages of pregnancy using iTRAQ quantitative proteomicsDanqing Zhao, Liming Shen, Yan Wei, et al.
Future Oncology (London, England)|October 26, 2023
Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysisJing Zhan, Shijie Yang, Wei Zhang, et al.
Annals of Hematology|November 6, 2023
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational studyDanqing Zhao, Yan Zhang, Wenjia Zhu, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Oncology|November 20, 2025
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort StudyZiqian Wang, Chong Wei, Kai-Ni Shen, et al.
Annals of Hematology|July 31, 2023
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two casesYupeng Wang, Zi Wang, Chong Wei, et al.
Annals of Hematology|May 15, 2026
TP53 mutations and baseline lymphocytes indicate response to glofitamab in relapsed or refractory diffuse large B-cell lymphomaJing Ruan, Yan Zhang, Daobin Zhou, et al.
Frontiers in Endocrinology|March 13, 2026
Long-term risk of all-cause mortality and cardiovascular events in women with gestational diabetes mellitus: a systematic review and meta-analysisHong Zeng, Xiaoping Yin, Li Yin, et al.
Medicine|March 10, 2023
Efficacy of catheter ablation for atrial fibrillation in patients with significant functional mitral regurgitationDanqing Zhao, Futao Zhang, Xiaojie Liu, et al.
Clinical and Experimental Medicine|March 1, 2024
Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcomeHongyun Chen, Jinrong Zhao, Danqing Zhao, et al.
Frontiers in Oncology|January 10, 2022
Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case SeriesYan Zhang, Yanan Li, Zhe Zhuang, et al.
Proteomics. Clinical Applications|February 22, 2017
Identification of candidate biomarkers for the prediction of gestational diabetes mellitus in the early stages of pregnancy using iTRAQ quantitative proteomicsDanqing Zhao, Liming Shen, Yan Wei, et al.
Future Oncology (London, England)|October 26, 2023
Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysisJing Zhan, Shijie Yang, Wei Zhang, et al.
Annals of Hematology|November 6, 2023
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational studyDanqing Zhao, Yan Zhang, Wenjia Zhu, et al.
Pageof 8